Evidence map›Paper›PMID 22174677›Full record

ArticlePLoS pathogens2011

Toward an integrated model of capsule regulation in Cryptococcus neoformans.

Brian C Haynes, Michael L Skowyra, Sarah J Spencer, Stacey R Gish, Matthew Williams, Elizabeth P Held, Michael R Brent, Tamara L Doering

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 77 papers.

0numbers the graph read from it
0cells of the map it votes in
77citing papers in PubMed
5.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

77 citing papers in PubMed, 104 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Effects of human immunoglobulin A onMicrobiology spectrum · 2025
    Article
  10. Article
  11. Regulation of melanin production in fungi.Frontiers in fungal biology · 2025
    Review
  12. Article
  13. Article
  14. A Quick reCAP: DiscoveringJournal of fungi (Basel, Switzerland) · 2024
    Article
  15. Comparative genomics ofbioRxiv : the preprint server for biology · 2024
    Article
  16. Article
  17. Article
  18. Article
  19. Importance of Clinical Isolates inJournal of fungi (Basel, Switzerland) · 2023
    Review
  20. Article

17 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Brian C HaynesCenter for Genome Sciences and Systems Biology and Departments of Computer Science and Genetics, Washington University School of Medicine, St. Louis, Missouri, United States of America.
Michael L Skowyra
Sarah J Spencer
Stacey R Gish
Matthew Williams
Elizabeth P Held
Michael R Brent
Tamara L Doering
Washington University in St. Louis · US

Funding

INSTITUTIONAL TRAINING GRANT IN GENOMIC SCIENCET32HG000045 · NHGRI · WASHINGTON UNIVERSITY · PI MICHAEL R BRENT, Barak A Cohen · 1997 to 2026
$8.4M
CAPSULE REGULATION AND VIRULENCE IN CRYPTOCOCCUS NEOFORMANSR01AI087794 · NIAID · WASHINGTON UNIVERSITY · PI BRENT, MICHAEL R, DOERING, TAMARA L · 2011 to 2020
$4.1M
GLYCAN BIOSYNTHESIS IN CRYPTOCOCCUS NEOFORMANSR01GM071007 · NIGMS · WASHINGTON UNIVERSITY · PI DOERING, TAMARA L · 2004 to 2010
$1.9M
NHGRI NIH HHS T32 HG000045NIAID NIH HHS R01 AI087794NIGMS NIH HHS R01 GM071007
6 · The paper itself

Abstract

Cryptococcus neoformans is an opportunistic fungal pathogen that causes serious human disease in immunocompromised populations. Its polysaccharide capsule is a key virulence factor which is regulated in response to growth conditions, becoming enlarged in the context of infection. We used microarray analysis of cells stimulated to form capsule over a range of growth conditions to identify a transcriptional signature associated with capsule enlargement. The signature contains 880 genes, is enriched for genes encoding known capsule regulators, and includes many uncharacterized sequences. One uncharacterized sequence encodes a novel regulator of capsule and of fungal virulence. This factor is a homolog of the yeast protein Ada2, a member of the Spt-Ada-Gcn5 Acetyltransferase (SAGA) complex that regulates transcription of stress response genes via histone acetylation. Consistent with this homology, the C. neoformans null mutant exhibits reduced histone H3 lysine 9 acetylation. It is also defective in response to a variety of stress conditions, demonstrating phenotypes that overlap with, but are not identical to, those of other fungi with altered SAGA complexes. The mutant also exhibits significant defects in sexual development and virulence. To establish the role of Ada2 in the broader network of capsule regulation we performed RNA-Seq on strains lacking either Ada2 or one of two other capsule regulators: Cir1 and Nrg1. Analysis of the results suggested that Ada2 functions downstream of both Cir1 and Nrg1 via components of the high osmolarity glycerol (HOG) pathway. To identify direct targets of Ada2, we performed ChIP-Seq analysis of histone acetylation in the Ada2 null mutant. These studies supported the role of Ada2 in the direct regulation of capsule and mating responses and suggested that it may also play a direct role in regulating capsule-independent antiphagocytic virulence factors. These results validate our experimental approach to dissecting capsule regulation and provide multiple targets for future investigation.

Indexed as

Amino Acid SequenceAnimalsChromatin ImmunoprecipitationCryptococcosisCryptococcus neoformansFemaleFungal ProteinsGene Expression ProfilingGene Expression Regulation, FungalHistone AcetyltransferasesMiceMice, Inbred C57BLMicroscopy, FluorescenceMolecular Sequence DataPolysaccharidesSequence Homology, Amino AcidFungal ProteinsHistone AcetyltransferasesPolysaccharidesVirulence Factors

Identifiers

PMID22174677
PMCPMC3234223
OpenAlexW2115175660

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.